Table 2 Results of the univariate Cox survival analyses.
Factor | Hazard ratio (95%CI) | p value |
|---|---|---|
Age ≥ 70 | 1.636 (0.782–3.426) | 0.192 |
Molecular subgroup (GCB type vs Non-GCB type) | 0.891 (0.359–2.213) | 0.804 |
MSKCC score (class 3 vs class 1 and 2) | 1.049 (0.479–2.295) | 0.905 |
Siglec-15 positive tumor cells | 1.241 (0.570–2.699) | 0.586 |
Siglec-15 positive intratumoral macrophages | 1.713 (0.783–3.748) | 0.178 |
Siglec-15 positive peritumoral macrophages | 0.404 (0.175–0.933) | 0.0339 |
PD-L1 positive tumor cells | 0.373 (0.149–0.931) | 0.0347 |
PD-L1 positive intratumoral macrophages | 1.369 (0.666–2.817) | 0.393 |
PD-L1 positive peritumoral macrophages | 0.585 (0.245–1.398) | 0.227 |
Rituximab | 0.999 (0.464–2.154) | 0.999 |
High-dose methotrexate-based chemotherapy | 0.417 (0.183–0.950) | 0.0373 |
